Developments in parathyroid hormone and related peptides as bone-formation agents.

Abstract:

:Osteoporosis is a major and growing healthcare concern. When administered by daily injection, parathyroid hormone (PTH) and its N-terminal fragments and analogs are potent bone-formation agents. Teriparatide, recombinant human PTH(1-34), is likely to be the first anabolic agent approved for treating osteoporosis, despite inducing osteosarcomas in rats. Native PTH and other PTH fragments and analogs are also in development. N-terminal fragments sometimes differ in activity from the native hormone, however, and the C-terminal region of PTH, acting through a receptor different from the classical PTH-1 receptor, initiates a variety of distinct biological activities. In particular, the C-terminal region of PTH, by promoting bone-cell apoptosis, may be important in opposing the anti-apoptotic effects of teriparatide in these cells, thereby maintaining normal bone-cell turnover. Because of these differences, care must be taken to consider the effects of native PTH and N-terminal PTH fragments and analogs separately.

journal_name

Curr Opin Pharmacol

authors

Fox J

doi

10.1016/s1471-4892(02)00154-6

keywords:

subject

Has Abstract

pub_date

2002-06-01 00:00:00

pages

338-44

issue

3

eissn

1471-4892

issn

1471-4973

pii

S1471489202001546

journal_volume

2

pub_type

杂志文章,评审
  • Emerging therapies in bone metastasis.

    abstract::Skeletal lesions contribute substantially to morbidity and mortality in patients with cancer. Emerging treatments for metastatic bone disease have arisen from our understanding of the biology of bone metastases. Tumour cells alter the functions of bone-resorbing (osteoclasts) and bone-forming (osteoblasts) cells, prom...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.04.004

    authors: Clément-Demange L,Clézardin P

    更新日期:2015-06-01 00:00:00

  • Therapeutic potential of marine n-3 fatty acids in CABG patients.

    abstract::Dietary intake of marine n-3 polyunsaturated fatty acids (PUFA) has beneficial effects in various cardiac disorders. Few studies have, however, investigated the therapeutic potential of n-3 PUFA in patients undergoing coronary artery bypass grafting (CABG). Five heterogeneous randomized studies on n-3 PUFA for prevent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.01.012

    authors: Andreasen JJ,Schmidt EB

    更新日期:2012-04-01 00:00:00

  • PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.

    abstract::Among the methods based on molecular imaging, the measure of the tracer uptake variation between a baseline and follow-up scan with the SUV and [(18)F]FDG-PET/CT is a very powerful tool for assessing response to treatment in oncology. However, the development of new targeted therapeutics and tissue pharmacokinetic eva...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.07.016

    authors: Tomasi G,Rosso L

    更新日期:2012-10-01 00:00:00

  • Inhibition of poly(ADP-ribose) polymerase in cancer.

    abstract::Inhibition of the DNA repair enzyme poly(ADP-ribose) polymerase-1 (PARP-1) has been extensively investigated in the pre-clinical setting as a strategy for chemo- or radio-potentiation. Recent evidence has suggested that PARP inhibitors might be active as single agents in certain rare inherited cancers that carry DNA r...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.02.004

    authors: Plummer ER

    更新日期:2006-08-01 00:00:00

  • Assaying dissociable elements of behavioural inhibition and impulsivity: translational utility of animal models.

    abstract::Inhibition is a fundamental property of behaviour required for flexible responding and humans have evolved executive brain systems that can engage inhibitory processes in order to reduce interference from irrelevant distracting stimuli, block unwanted memories and emotions and suppress inappropriate choices and action...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.06.006

    authors: Humby T,Wilkinson LS

    更新日期:2011-10-01 00:00:00

  • Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms.

    abstract::The repertoire of signal transduction pathways activated by dopamine in brain includes the increase of intracellular calcium. However the mechanism(s) by which dopamine activated this important second messenger system was/were unknown. Although we showed that activation of the D5 dopamine receptor increased calcium co...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.09.011

    authors: Hasbi A,O'Dowd BF,George SR

    更新日期:2010-02-01 00:00:00

  • 5-HT and the immune system.

    abstract::The classical neurotransmitter, serotonin (5-HT), plays an important role outside of the central nervous system in immune signaling. Here I review recent studies describing 5-HT uptake in dendritic cells and B lymphocytes, 5-HT synthesis in T lymphocytes, and the role of specific 5-HT receptor subtypes in innate and a...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.02.004

    authors: Ahern GP

    更新日期:2011-02-01 00:00:00

  • Siglecs in innate immunity.

    abstract::Siglecs are sialic acid-binding Ig-like lectins expressed in a highly specific manner, and which are implicated in signaling and adhesive functions. The CD33-related siglecs represent a distinct subgroup that is undergoing rapid evolution within the innate immune system, with the potential to trigger apoptosis and pro...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.03.003

    authors: Crocker PR

    更新日期:2005-08-01 00:00:00

  • Retrieving GPCR data from public databases.

    abstract::Improvements in databases have already impacted GPCR research. The purpose of the review is to give a snapshot of the GPCR data available and provide utility examples. Consequently, this review covers a small set of major databases, including UniProt for proteins, Ensembl for genes, ChEMBL for bioactive chemistry and ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.07.002

    authors: Southan C

    更新日期:2016-10-01 00:00:00

  • Human therapeutic antibodies.

    abstract::The development of genetic engineering technologies has today advanced to the point where the generation of high-affinity human antibodies against therapeutic targets is not a major hurdle. Rather, it is the selection of target molecules in, for example, cancer therapy that poses a challenge. Targets that are not mere...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00070-4

    authors: Borrebaeck CA,Carlsson R

    更新日期:2001-08-01 00:00:00

  • Epidermal growth factor receptor tyrosine kinase inhibitors.

    abstract::Clinical trials of selective small-molecule inhibitors of epidermal growth factor receptor tyrosine kinase activity have shown that these targeted inhibitors of proliferative signal transduction provide well-tolerated antitumour activity in patients. Preclinical pharmacology studies illustrate the potential use of the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00183-2

    authors: Wakeling AE

    更新日期:2002-08-01 00:00:00

  • CGRP receptors in the control of pain and inflammation.

    abstract::Calcitonin gene related peptide (CGRP) has been proposed to contribute to pain transmission and inflammation and for these reasons to the mechanism of migraine. CGRP is, in fact, expressed in and released from a subset of polymodal primary sensory neurons of the trigeminal ganglion. Release of CGRP in the dorsal spina...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.12.007

    authors: Benemei S,Nicoletti P,Capone JG,Geppetti P

    更新日期:2009-02-01 00:00:00

  • Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome.

    abstract::Irritable bowel syndrome, which affects 5-10% of the population includes around 25% with predominantly diarrhoea (IBS-D). Several lines of evidence suggest an increase in mucosal 5-HT availability in IBS-D including a decrease in the serotonin transporter (SERT) which is also seen following acute diverticulitis. 5-HT(...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.02.005

    authors: Spiller RC

    更新日期:2011-02-01 00:00:00

  • Brk/PTK6 signaling in normal and cancer cell models.

    abstract::Breast tumor kinase (Brk), also termed PTK6, is known to function in cell-type and context-dependent processes governing normal differentiation. However, in tumors in which Brk is overexpressed, this unusual soluble tyrosine kinase is emerging as a mediator of cancer cell phenotypes, including increased proliferation,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.08.007

    authors: Ostrander JH,Daniel AR,Lange CA

    更新日期:2010-12-01 00:00:00

  • Promoting apoptosis in disease management: a panacea or Trojan horse?

    abstract::In our enthusiasm to advocate apoptosis as a therapeutic strategy for the management of disease we need to be mindful that the clearance of apoptotic cells is itself immunomodulatory and that it may not always be as benign or beneficial as we think. Indeed, the existence of free apoptotic cells in situ may potentially...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.02.005

    authors: Brown SB,Vernon-Wilson EF

    更新日期:2005-08-01 00:00:00

  • Drug delivery to the upper small intestine window using gastroretentive technologies.

    abstract::The bioavailability of drugs with an absorption window in the upper small intestine is generally limited with conventional pharmaceutical dosage forms. The residence time of such systems and, thus, of their drug release into the stomach and upper intestine is often short. To overcome this restriction and to increase t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.04.007

    authors: Streubel A,Siepmann J,Bodmeier R

    更新日期:2006-10-01 00:00:00

  • VEGF as a potential target for therapeutic intervention in depression.

    abstract::Antidepressants are among the most widely prescribed drugs, however the mechanism underlying their therapeutic efficacy is not known. Neurotrophic factors represent a promising class of targets for antidepressant treatments. We recently characterized a role for vascular endothelial growth factor (VEGF) in cellular and...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.10.013

    authors: Warner-Schmidt JL,Duman RS

    更新日期:2008-02-01 00:00:00

  • Platelet purinergic receptors.

    abstract::Activation of P2Y(1) and P2Y(12) receptors, through secreted ADP that is stimulated by agonists such as thrombin, thromboxane and collagen, is a major mechanism of platelet activation. P2X(1) receptors also participate in platelet shape change and potentiation of calcium mobilization. The cloning of the P2Y(12) recept...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00007-9

    authors: Kunapuli SP,Dorsam RT,Kim S,Quinton TM

    更新日期:2003-04-01 00:00:00

  • Angiotensin type 2 receptors: blood pressure regulation and end organ damage.

    abstract::In most situations, the angiotensin AT2-receptor (AT2R) mediates physiological actions opposing those mediated by the AT1-receptor (AT1R), including a vasorelaxant effect. Nevertheless, experimental evidence vastly supports that systemic application of AT2R-agonists is blood pressure neutral. However, stimulation of A...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.01.004

    authors: Sumners C,de Kloet AD,Krause EG,Unger T,Steckelings UM

    更新日期:2015-04-01 00:00:00

  • Oestrogen's regulation of fat metabolism during exercise and gender specific effects.

    abstract::Early animal, menstrual phase and gender comparative studies inconsistently support an oestrogen-induced increase in fat oxidation during exercise. Recent advances from studies of cellular signalling and gene expression provide evidence for inter-tissue and intramuscular mechanisms that demonstrate oestrogen's promoti...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.02.008

    authors: Oosthuyse T,Bosch AN

    更新日期:2012-06-01 00:00:00

  • Gastroesophageal reflux disease.

    abstract::Gastroesophageal reflux disease (GERD) is increasingly common worldwide; symptoms differ between individuals and endoscopically visible injury is present in only about 50% of cases. Although GERD is a disorder of gastrointestinal motility and structure, the most effective therapy is based on the use of acid antisecret...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.09.001

    authors: Armstrong D

    更新日期:2005-12-01 00:00:00

  • The role of chemokines in intestinal inflammation and cancer.

    abstract::Chronic inflammation is a risk factor for several gastrointestinal malignancies, including colorectal cancer. Recent epidemiological studies and clinical trials demonstrate that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) markedly reduced the relative risk of colorectal cancer. Chronic inflammation...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.08.003

    authors: Wang D,Dubois RN,Richmond A

    更新日期:2009-12-01 00:00:00

  • MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.

    abstract::The molecular genetics of Barrett's esophagus (BE) and its evolution to esophageal adenocarcinoma (EAC) have been widely studied; however, the molecular mechanism of BE-EAC carcinogenesis has not been completely understood. MicroRNA (miRNA) is now essential to understand the molecular mechanism of cancer progression. ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.08.009

    authors: Kan T,Meltzer SJ

    更新日期:2009-12-01 00:00:00

  • Immunomodulation in stem-cell transplantation.

    abstract::Acute graft-versus-host disease is a complication that affects 30-60% of patients undergoing allogeneic stem-cell transplantation. The standard for prophylaxis for graft-versus-host disease has historically been the combination of cyclosporine and methotrexate. Recently, tacrolimus has been used more frequently and cu...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00174-1

    authors: Abo-Zena RA,Horwitz ME

    更新日期:2002-08-01 00:00:00

  • Recent advances in combinatorial drug screening and synergy scoring.

    abstract::Treatment of complex diseases such as cancer, cardiovascular disease, diabetes or neurological disorders frequently warrants the utilization of drug combinations for therapeutic intervention. In fact, the most successful example is the current standard of care for HIV patients. However, identification of successful dr...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.07.008

    authors: Pemovska T,Bigenzahn JW,Superti-Furga G

    更新日期:2018-10-01 00:00:00

  • Clinical pharmacokinetic-pharmacodynamic analyses: a critical element for developing antibacterial agents.

    abstract::In the current of era of developing antibacterial agents, including those for unmet medical need, Sponsors are required to submit a robust pre-clinical pharmacokinetic-pharmacodynamic (PK-PD) data package in exchange for limited clinical data. However, the clinical data package also needs to be as robust as possible. ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.09.010

    authors: Bhavnani SM,Hammel JP

    更新日期:2017-10-01 00:00:00

  • GABA-based therapeutic approaches: GABAA receptor subtype functions.

    abstract::It is increasingly being appreciated that GABAA receptor subtypes, through their specific regional, cellular and subcellular localization, are linked to distinct neuronal circuits and consequently serve distinct functions. GABAA receptor subtype-selective drugs are therefore expected to provide novel pharmacological p...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.10.003

    authors: Rudolph U,Möhler H

    更新日期:2006-02-01 00:00:00

  • Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant?

    abstract::Inverse agonism has gone from an initial curiosity to a now well-recognized phenomenon. This has demanded expansion of receptor theory models to account for multiple receptor states and a re-definition of ligand efficacy. However, after several decades of discovery, the clinical importance of inverse agonist ligands i...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.10.005

    authors: Parra S,Bond RA

    更新日期:2007-04-01 00:00:00

  • Synaptic localization of neurotransmitter receptors: comparing mechanisms for AMPA and GABAA receptors.

    abstract::Ionotropic neurotransmitter receptors mediate fast synaptic transmission by localizing at postsynapses. Changes in receptor number at synapses induce synaptic plasticity. Thus, mechanisms for the synaptic localization of receptors in basal transmission and synaptic plasticity have been investigated extensively. Recent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.11.011

    authors: Martenson JS,Tomita S

    更新日期:2015-02-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections.

    abstract::High occurrence of penicillin-resistant and multidrug-resistant Streptococcus pneumoniae and reports of resistance with Haemophilus influenzae and Moraxella catarrhalis are influencing the empiric treatment of community-acquired respiratory infections and allowing the new fluoroquinolones to serve as important treatme...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00080-7

    authors: Zhanel GG,Noreddin AM

    更新日期:2001-10-01 00:00:00